GDUFA Negotiations Shift To 'Tiered' Fee Models
Finance subgroup talks about new structure for generic drug user fee program that could mean bigger firms would pay more.
You may also be interested in...
Since applications comprise most of the workload, they will be the focus in the next generic drug user fee cycle.
Generics industry and FDA have resolved remaining issues regarding financing of user fee program.
Several facility fees will increase next year as application fees drop.